Biomarker and Diagnostics Strategy

This is where precision medicine starts – whether you’re trying to find the right tools to uncover new biomarkers, identify CDx partners, launch an IVD, or understand how your assay will fit into the clinical journey, DeciBio has you covered. Nobody knows biomarkers and CDx better than DeciBio.

Our Experts

Andrew Aijian

Stephane Budel

David Cavanaugh

David Cavanaugh

Schedule a Call

Related Client Results

All Client Results

Diagnostic Advisory Board

A diagnostics company asked DeciBio to convene an advisory board (ad board) to help it position its relatively new somatic oncology genomic profiling product in an already competitive market

Voice-of-Customer Research

KOL Identification

AdBoards

Carrier Screening Landscape Assessment

A leading diagnostics player wanted an assessment of the current and future carrier screening landscape to guide their product development strategy

Voice-of-Customer Research

Genetic Testing Company Assessment

A group asked DeciBio to identify and evaluate clinical genetic testing labs for potential acquisition

Target Identification

Internal Lab Buildout Strategy

A large pharmaceutical company engaged DeciBio to evaluate strategies for an internal build of a lab to support clinical and commercial opportunities in oncology

Voice-of-Customer Research

Due Diligence

Life Science Tools & Manufacturing

Sequencing Technology Go-to-Market Strategy

A research tools start-up enlisted DeciBio to support their go-to-market strategy and activities for their novel sequencing technology by conducting pricing voice-of-customer research and evaluating potential pricing strategies

Voice-of-Customer Research

Go-to-Market Strategy

Pricing Strategy

Competitive Analysis

Cell Therapy Market Trends and Revenue Forecast

A cell therapy developer preparing for a NASDAQ listing needed financial projections, a valuation, and support on investor messaging

Revenue Projection

Precision Medicine is evolving at a rapid pace

Discover how we can help